Quest Diagnostics 통합
US ˙ NYSE ˙ US74834L1008

SecurityDGX / Quest Diagnostics Incorporated
InstitutionGlg Llc
Latest Disclosed Ownership25,662 shares
Latest Disclosed Value $ 2,527,000
Glg Llc ownership in DGX / Quest Diagnostics Incorporated

On February 14, 2018 - Glg Llc filed a 13F-HR form disclosing ownership of 25,662 shares of Quest Diagnostics Incorporated (US:DGX) valued at $2,527,450 USD as of December 31, 2017. The entity filed a previous 13F-HR on November 14, 2017 disclosing 25,662 shares of Quest Diagnostics Incorporated. This represents a change in shares of 0.00% during the quarter. The current value of the position is $5,139,842 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2018-02-14 2017-12-31 13F QUEST DIAGNOSTICS COM 74834L100 25,662 0 0.00 2,527 5.16 0.1812
2017-11-14 2017-09-30 13F QUEST DIAGNOSTICS COM 74834L100 25,662 -2,386 -8.51 2,403 -22.93 0.1559
2017-08-14 2017-06-30 13F QUEST DIAGNOSTICS COM 74834L100 28,048 19,064 212.20 3,118 253.51 0.1914
2017-05-15 2017-03-31 13F QUEST DIAGNOSTICS COM 74834L100 8,984 -20 -0.22 882 6.65 0.0487
2017-02-14 2016-12-31 13F QUEST DIAGNOSTICS COM 74834L100 9,004 573 6.80 827 15.83 0.0571
2016-11-14 2016-09-30 13F QUEST DIAGNOSTICS COM 74834L100 8,431 -706 -7.73 714 -4.03 0.0510
2016-08-15 2016-06-30 13F QUEST DIAGNOSTICS COM 74834L100 9,137 -1,375 -13.08 744 -0.93 0.0560
2016-05-16 2016-03-31 13F QUEST DIAGNOSTICS COM 74834L100 10,512 -138 -1.30 751 -0.92 0.0469
2016-02-16 2015-12-31 13F QUEST DIAGNOSTICS COM 74834L100 10,650 -5,190 -32.77 758 -22.18 0.0451
2015-11-16 2015-09-30 13F QUEST DIAGNOSTICS COM 74834L100 15,840 -52 -0.33 974 -15.45 0.0244
2015-08-14 2015-06-30 13F QUEST DIAGNOSTICS COM 74834L100 15,892 -246 -1.52 1,152 -7.10 0.0245
2015-05-15 2015-03-31 13F QUEST DIAGNOSTICS COM 74834L100 16,138 1,472 10.04 1,240 26.02 0.0353
2015-02-17 2014-12-31 13F QUEST DIAGNOSTICS COM 74834L100 14,666 0 0.00 984 10.56 0.0295
2014-11-14 2014-09-30 13F QUEST DIAGNOSTICS COM 74834L100 14,666 0 0.00 890 3.37 0.0237
2014-08-14 2014-06-30 13F QUEST DIAGNOSTICS COM 74834L100 14,666 0 0.00 861 1.41 0.0255
2014-05-15 2014-03-31 13F QUEST DIAGNOSTICS COM 74834L100 14,666 14,666 849 0.0285
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.